CFB Client iCell Gene Therapeutics, Stony Brook University, and the University of Louisville, have received FDA clearance for an Investigational New Drug (IND) for the treatment of relapsed and refractory T-cell leukemia and lymphoma.
Learn MoreThe Gund-Harrington Initiative for Fighting Blindness announces the call for proposals for the 2019 Gund-Harrington Scholar Award. The Gund-Harrington Scholar Award supports innovative research efforts that could prevent, treat or cure blindness resulting from inherited retinal degenerative diseases. The Gund-Harrington …
Learn MoreLifeSci NYC has announced the launch of the seventh year of its life sciences entrepreneur training and networking program – Entrepreneurship Lab NYC (ELabNYC). Applications for the 2019 program are now being accepted. ELabNYC is a six-month entrepreneurship training and networking program …
Learn More“With a proven record of research, discovery, innovation and product-development in the biomedical sciences, Stony Brook’s Center for Biotechnology is poised to become an important contributor to the BARDA-DRIVe initiative”
Learn MoreBoris Shor, one of the Center for Biotechnology’s newest BioEntrepreneurs-in-Residence, has earned a place for his start-up, Manhattan Biosolutions, in Johnson and Johnson Innovations latest facility, JLABS @ NYC, as one of four winners of the company’s prestigious QuickFire Challenge. The …
Learn MoreFormer Pfizer Senior Scientist and Scout will focus on the development and implementation of technology and business development strategies.
Learn More